Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bayer, PCB
Jury orders Bayer to pay $100 million over PCBs in Washington school
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals known as PCBs at a Seattle-area school, but found the company was not liable for injuries alleged by 11 others.
Bayer Hit with $100 Million Verdict Over Toxic PCB Exposure
Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to toxic chemicals.
Bayer Says It Was Told by Jury to Pay $100 Million Over Toxic Chemicals
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Bayer must pay $100 million in latest trial over PCBs in Washington school, jury finds
A Washington state jury on Tuesday said Bayer must pay $100 million to four people who say they were sickened by exposure to toxic chemicals known as PCBs made by the company's predecessor Monsanto that were used in light fixtures at a Seattle-area school,
8h
on MSN
Vanessa Bayer lied to family about joining “SNL” due to 'horror stories' of cast blabbing too early
For Vanessa Bayer, that includes keeping the news that she was cast on Saturday Night Live a secret. The former SNL star ...
1h
Ex-SNL star Vanessa Bayer reveals why she lied to family about joining hit show: ‘You cannot tell a soul’
Comedian Vanessa Bayer heard “horror stories” about other cast members revealing they were cast on SNL before an official announcement was made.
FiercePharma
7h
JPM25: Bayer gears up for 'must-win battles' as Xarelto loss of exclusivity in full swing, says pharma chief
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
2d
on MSN
Bayer’s Head of Pharma Oelrich Expects Business to Return to Growth in 2027
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
19h
Bayer | Morning Blend
As we usher in 2025, it’s the perfect time to prioritize health and wellness. Registered Dietitian and Nutritionist Kelly ...
7d
Cutting Middle Management: Bayer's Costly Experiment One Year Later
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
1d
on MSN
Bayer plant doch keine Pharma-Großdeals, Fokus Schuldenabbau
Mit Blick auf die Neuausrichtung der Medikamentenpipeline von Bayer hatte Pharma-Chef Stefan Oelrich im letzten Januar ...
6d
Bayer says menopause drug succeeds in breast cancer study
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
FierceBiotech
3d
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
The Western Producer
9h
Bayer introduces FieldView Drive 2.0 at Crop Production Show 2025
Bayer used the Western Canadian Crop Production Show in Saskatoon this week to introduce Prairie farmers to its new FieldView ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Mainz
PCB
Parkinson's disease
Feedback